• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于不同模块的基因集指数可能有助于区分阿尔茨海默病和血管性痴呆的发病机制。

Gene Set Index Based on Different Modules May Help Differentiate the Mechanisms of Alzheimer's Disease and Vascular Dementia.

机构信息

Department of Neurology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People's Republic of China.

Department of Neurology, The First People's Hospital of Nanning, Nanning, Guangxi, 530022, People's Republic of China.

出版信息

Clin Interv Aging. 2021 Mar 11;16:451-463. doi: 10.2147/CIA.S297483. eCollection 2021.

DOI:10.2147/CIA.S297483
PMID:33737807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961151/
Abstract

PURPOSE

Alzheimer's disease (AD) and vascular dementia shared similar symptoms, the aim of the present study was to identify potential differences in the mechanisms underlying the two diseases.

MATERIALS AND METHODS

The data set including AD, vascular dementia, and control samples was carried out gene differential expression analysis, weighted gene co-expression network analysis, functional enrichment, protein-protein interaction network construction, and least absolute shrinkage and selection operator analysis to reveal the differences in the mechanisms underlying the two diseases and potential diagnostic gene signature.

RESULTS

We identified the gene modules related to AD or vascular dementia. Enrichment analysis of module genes and construction of a protein-protein interaction network suggested that the "brown" module may be involved in a chemokine pathway, the "blue" module may be involved in cortisol synthesis and secretion, and the "turquoise" module may be involved in cholinergic synapse transmission. The hub gene-based signature index may be a biomarker of AD and vascular dementia and may even differentiate the two diseases from each other with high area under curve.

CONCLUSION

Our results identified not only core pathways involved in both AD and vascular disease, but also their potentially specific pathways. We proposed the hub gene-based signature index may be useful for diagnosing AD and vascular dementia.

摘要

目的

阿尔茨海默病(AD)和血管性痴呆具有相似的症状,本研究旨在确定这两种疾病潜在的发病机制差异。

材料和方法

对包括 AD、血管性痴呆和对照样本在内的数据集进行基因差异表达分析、加权基因共表达网络分析、功能富集、蛋白质-蛋白质相互作用网络构建和最小绝对收缩和选择算子分析,以揭示两种疾病潜在的诊断基因特征及发病机制的差异。

结果

我们确定了与 AD 或血管性痴呆相关的基因模块。模块基因的富集分析和蛋白质-蛋白质相互作用网络的构建表明,“棕色”模块可能参与趋化因子途径,“蓝色”模块可能参与皮质醇的合成和分泌,“绿松石”模块可能参与胆碱能突触传递。基于枢纽基因的特征指数可能是 AD 和血管性痴呆的生物标志物,甚至可以通过高曲线下面积将这两种疾病区分开来。

结论

我们的研究结果不仅确定了 AD 和血管性疾病共有的核心通路,还确定了它们可能具有特异性的通路。我们提出基于枢纽基因的特征指数可能有助于 AD 和血管性痴呆的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/317fe2d367bb/CIA-16-451-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/7fdab483aaa0/CIA-16-451-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/cb5fd4c13c63/CIA-16-451-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/3604d7bb377d/CIA-16-451-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/560b0e317b8b/CIA-16-451-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/599cfe52bf7f/CIA-16-451-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/8b70ecd63092/CIA-16-451-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/5d35d5695e3e/CIA-16-451-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/317fe2d367bb/CIA-16-451-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/7fdab483aaa0/CIA-16-451-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/cb5fd4c13c63/CIA-16-451-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/3604d7bb377d/CIA-16-451-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/560b0e317b8b/CIA-16-451-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/599cfe52bf7f/CIA-16-451-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/8b70ecd63092/CIA-16-451-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/5d35d5695e3e/CIA-16-451-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46af/7961151/317fe2d367bb/CIA-16-451-g0008.jpg

相似文献

1
Gene Set Index Based on Different Modules May Help Differentiate the Mechanisms of Alzheimer's Disease and Vascular Dementia.基于不同模块的基因集指数可能有助于区分阿尔茨海默病和血管性痴呆的发病机制。
Clin Interv Aging. 2021 Mar 11;16:451-463. doi: 10.2147/CIA.S297483. eCollection 2021.
2
[Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis].通过加权基因共表达网络分析鉴定阿尔茨海默病的潜在枢纽基因
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Dec 20;41(12):1752-1762. doi: 10.12122/j.issn.1673-4254.2021.12.01.
3
Integrated Analysis of Weighted Gene Coexpression Network Analysis Identifying Six Genes as Novel Biomarkers for Alzheimer's Disease.加权基因共表达网络分析的综合分析确定了六个基因作为阿尔茨海默病的新型生物标志物。
Oxid Med Cell Longev. 2021 Jul 26;2021:9918498. doi: 10.1155/2021/9918498. eCollection 2021.
4
Identification of Potential Therapeutic Targets of Alzheimer's Disease By Weighted Gene Co-Expression Network Analysis.通过加权基因共表达网络分析鉴定阿尔茨海默病的潜在治疗靶点
Chin Med Sci J. 2020 Dec 31;35(4):330-341. doi: 10.24920/003695.
5
Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.通过共表达网络分析探索阿尔茨海默病和2型糖尿病的共同发病机制
Curr Alzheimer Res. 2020;17(6):566-575. doi: 10.2174/1567205017666200810164932.
6
REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia.REPS1作为阿尔茨海默病和血管性痴呆的潜在生物标志物。
Front Aging Neurosci. 2022 Jun 22;14:894824. doi: 10.3389/fnagi.2022.894824. eCollection 2022.
7
Identification of Autophagy-Related Candidate Genes in the Early Diagnosis of Alzheimer's Disease and Exploration of Potential Molecular Mechanisms.阿尔茨海默病早期诊断中自噬相关候选基因的鉴定及潜在分子机制的探索。
Mol Neurobiol. 2024 Sep;61(9):6584-6598. doi: 10.1007/s12035-024-04011-z. Epub 2024 Feb 8.
8
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.对19个脑区的综合网络分析确定了阿尔茨海默病选择性区域易损性背后的分子特征和网络。
Genome Med. 2016 Nov 1;8(1):104. doi: 10.1186/s13073-016-0355-3.
9
Identification of vascular dementia and Alzheimer's disease hub genes expressed in the frontal lobe and temporal cortex by weighted co-expression network analysis and construction of a protein-protein interaction.基于加权共表达网络分析和构建蛋白质-蛋白质相互作用鉴定额叶和颞叶皮质中血管性痴呆和阿尔茨海默病的枢纽基因。
Int J Neurosci. 2022 Oct;132(10):1049-1060. doi: 10.1080/00207454.2020.1860966. Epub 2021 Jan 18.
10
Cross-Talking Pathways of Rapidly Accelerated Fibrosarcoma-1 (RAF-1) in Alzheimer's Disease.阿尔茨海默病中快速加速纤维肉瘤-1(RAF-1)的交叉对话途径。
Mol Neurobiol. 2024 May;61(5):2798-2807. doi: 10.1007/s12035-023-03765-2. Epub 2023 Nov 8.

引用本文的文献

1
Chemokines play a role in nerve damage and neuroprotection in vascular dementia.趋化因子在血管性痴呆的神经损伤和神经保护中发挥作用。
IBRO Neurosci Rep. 2024 Aug 5;17:154-160. doi: 10.1016/j.ibneur.2024.08.002. eCollection 2024 Dec.
2
Single-Nucleus Landscape of Glial Cells and Neurons in Alzheimer's Disease.阿尔茨海默病中神经胶质细胞和神经元的单核图谱
Mol Neurobiol. 2025 Mar;62(3):2695-2709. doi: 10.1007/s12035-024-04428-6. Epub 2024 Aug 17.
3
Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.

本文引用的文献

1
Identification of molecular correlations of RBM8A with autophagy in Alzheimer's disease.鉴定RBM8A与阿尔茨海默病自噬的分子关联
Aging (Albany NY). 2019 Dec 9;11(23):11673-11685. doi: 10.18632/aging.102571.
2
Shortcuts for faster image creation in PyMOL.在 PyMOL 中创建图像的快捷方式。
Protein Sci. 2020 Jan;29(1):268-276. doi: 10.1002/pro.3781. Epub 2019 Nov 27.
3
Analysis of transcription factor- and ncRNA-mediated potential pathogenic gene modules in Alzheimer's disease.阿尔茨海默病中转录因子和非编码RNA介导的潜在致病基因模块分析
阿尔茨海默病中 miR-181c-5p 的下调削弱了小胶质细胞对 Aβ 吞噬的反应。
Sci Rep. 2024 May 20;14(1):11487. doi: 10.1038/s41598-024-62347-x.
4
Exploration of novel biomarkers in Alzheimer's disease based on four diagnostic models.基于四种诊断模型探索阿尔茨海默病的新型生物标志物
Front Aging Neurosci. 2023 Feb 16;15:1079433. doi: 10.3389/fnagi.2023.1079433. eCollection 2023.
5
Potential biomarkers of Alzheimer's disease and cerebral small vessel disease.阿尔茨海默病和脑小血管病的潜在生物标志物。
Front Mol Neurosci. 2022 Oct 10;15:996107. doi: 10.3389/fnmol.2022.996107. eCollection 2022.
6
Exploring Early Physical Examination Diagnostic Biomarkers for Alzheimer's Disease Based on Least Absolute Shrinkage and Selection Operator.基于最小绝对值收缩和选择算子的阿尔茨海默病早期体格检查诊断生物标志物研究。
Comput Math Methods Med. 2022 Aug 18;2022:3039248. doi: 10.1155/2022/3039248. eCollection 2022.
7
Identification of molecular signatures associated with sleep disorder and Alzheimer's disease.与睡眠障碍和阿尔茨海默病相关的分子特征的鉴定。
Front Psychiatry. 2022 Aug 4;13:925012. doi: 10.3389/fpsyt.2022.925012. eCollection 2022.
8
REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia.REPS1作为阿尔茨海默病和血管性痴呆的潜在生物标志物。
Front Aging Neurosci. 2022 Jun 22;14:894824. doi: 10.3389/fnagi.2022.894824. eCollection 2022.
9
Identification of Alzheimer's Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing.基于平行大规模测序的阿尔茨海默病分子亚型鉴定
Front Aging Neurosci. 2022 Apr 28;14:770136. doi: 10.3389/fnagi.2022.770136. eCollection 2022.
10
Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication.小胶质细胞通过配体-受体轴通讯介导阿尔茨海默病的发生和发展。
Front Aging Neurosci. 2021 Sep 20;13:731180. doi: 10.3389/fnagi.2021.731180. eCollection 2021.
Aging (Albany NY). 2019 Aug 16;11(16):6109-6119. doi: 10.18632/aging.102169.
4
Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.从系统生物医学角度鉴定阿尔茨海默病的分子特征和途径,以确定新的治疗靶点。
Genomics. 2020 Mar;112(2):1290-1299. doi: 10.1016/j.ygeno.2019.07.018. Epub 2019 Aug 1.
5
An integrated quantitative structure and mechanism of action-activity relationship model of human serum albumin binding.人血清白蛋白结合的综合定量结构与作用机制-活性关系模型
J Cheminform. 2019 Jun 6;11(1):38. doi: 10.1186/s13321-019-0359-2.
6
Electrophysiological brain signatures for the classification of subjective cognitive decline: towards an individual detection in the preclinical stages of dementia.用于主观认知衰退分类的电生理脑特征:在痴呆的临床前阶段进行个体检测。
Alzheimers Res Ther. 2019 Jun 1;11(1):49. doi: 10.1186/s13195-019-0502-3.
7
Discovering Biomarkers and Pathways Shared by Alzheimer's Disease and Ischemic Stroke to Identify Novel Therapeutic Targets.发现阿尔茨海默病和缺血性中风共享的生物标志物和途径,以确定新的治疗靶点。
Medicina (Kaunas). 2019 May 22;55(5):191. doi: 10.3390/medicina55050191.
8
Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease.基于网络的方法鉴定阿尔茨海默病的分子特征和治疗药物。
Comput Biol Chem. 2019 Feb;78:431-439. doi: 10.1016/j.compbiolchem.2018.12.011. Epub 2018 Dec 26.
9
Association between polymorphisms in microRNAs and ischemic stroke in an Asian population: evidence based on 6,083 cases and 7,248 controls.亚洲人群中 microRNAs 多态性与缺血性脑卒中的相关性:基于 6083 例病例和 7248 例对照的证据。
Clin Interv Aging. 2018 Sep 12;13:1709-1726. doi: 10.2147/CIA.S174000. eCollection 2018.
10
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.植物化学物质作为 NF-κB 的抑制剂用于治疗老年痴呆症。
Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.